Since elevated COX-2 and PGE2 levels are indicators of poor prognosis in several types of cancer including breast, and we have shown that MRP4 contributes to the amount of PGE2 produced by breast cancer cells, we investigated the role of MRP4 on both primary tumor growth and metastatic potential. The gene discussed is PTGS2; the disease is breast cancer.